Ratnavalli Ellajosyula

Ratnavalli Ellajosyula

Auto-generated profile, based on publicly available information

Ratnavalli Ellajosyula

Annasawmy Mudaliar General Hospital Bangalore India

Research Focus & Metrics

Academic Career Length

27Years (2000-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 June 2002 in Neurology
Verified
Journal Article
Closed access
PDF file
ERE. Ratnavalli
E. Ratnavalli
CBCarol Brayne
Carol Brayne
KDK. Dawson
K. Dawson
JHJ. R. Hodges
J. R. Hodges
Objective: To estimate the prevalence of frontotemporal dementia (FTD) and other degenerative early-onset dementias in a geographically defined population. Background: Early-onset dementia (at age <65 years) results in high psychiatric morbidity and caregiver burden. Prevalence figures are available for early-onset AD but not for FTD, a dementia that is almost invariably of early onset. Methods: Case ascertainment was by review of case records of three specialist clinic databases and inpatient admissions at a university hospital in Cambridge, United Kingdom, for patients with dementia who were <65 years of age, living in Cambridge City or East or South Cambridgeshire (population 326,019) on May 30, 2000. All the relevant health services in the area were also contacted for potential cases. Diagnosis of various dementias was based on published criteria. All patients with potential FTD were examined by the study investigators and underwent structural neuroimaging. The 1998 population estimates for the area were used to calculate age and sex prevalence with confidence intervals for AD, FTD, and other causes of dementia. Results: A total of 108 patients (66 men and 42 women) with dementia with onset before they were 65 years of age were identified, of whom 60 were <65 years on the census date, giving an overall prevalence of 81 (95% CI, 62.8 to 104.5) per 100,000 in the 45- to 64-year age group. The prevalences of early-onset FTD and AD were the same: 15 per 100,000 (8.4 to 27.0) in the 45- to 64-year-old population. The mean age at onset of FTD was 52.8 years and there was a striking male preponderance (14:3). It is possible case ascertainment methods resulted in a relative underrepresentation of some forms of dementia. Conclusions: Frontotemporal dementia is a more common cause of early-onset dementia than previously recognized and appears to be more common in men.

1 June 2020 in Brain
Verified
Journal Article
Open access
PDF file
SDSimon Ducharme
Simon Ducharme
ADAnnemiek Dols
Annemiek Dols
RLRobert Laforce
Robert Laforce
EDEmma Devenney
Emma Devenney
Fiona KumforFiona Kumfor
Fiona Kumfor
YPYolande Pijnenburg
Yolande Pijnenburg
The behavioural variant of frontotemporal dementia (bvFTD) is a frequent cause of early-onset dementia. The diagnosis of bvFTD remains challenging because of the limited accuracy of neuroimaging in the early disease stages and the absence of molecular biomarkers, and therefore relies predominantly on clinical assessment. BvFTD shows significant symptomatic overlap with non-degenerative primary psychiatric disorders including major depressive disorder, bipolar disorder, schizophrenia, obsessive-compulsive disorder, autism spectrum disorders and even personality disorders. To date, ∼50% of patients with bvFTD receive a prior psychiatric diagnosis, and average diagnostic delay is up to 5–6 years from symptom onset. It is also not uncommon for patients with primary psychiatric disorders to be wrongly diagnosed with bvFTD. The Neuropsychiatric International Consortium for Frontotemporal Dementia was recently established to determine the current best clinical practice and set up an international collaboration to share a common dataset for future research. The goal of the present paper was to review the existing literature on the diagnosis of bvFTD and its differential diagnosis with primary psychiatric disorders to provide consensus recommendations on the clinical assessment. A systematic literature search with a narrative review was performed to determine all bvFTD-related diagnostic evidence for the following topics: bvFTD history taking, psychiatric assessment, clinical scales, physical and neurological examination, bedside cognitive tests, neuropsychological assessment, social cognition, structural neuroimaging, functional neuroimaging, CSF and genetic testing. For each topic, responsible team members proposed a set of minimal requirements, optimal clinical recommendations, and tools requiring further research or those that should be developed. Recommendations were listed if they reached a ≥ 85% expert consensus based on an online survey among all consortium participants. New recommendations include performing at least one formal social cognition test in the standard neuropsychological battery for bvFTD. We emphasize the importance of 3D-T1 brain MRI with a standardized review protocol including validated visual atrophy rating scales, and to consider volumetric analyses if available. We clarify the role of 18F-fluorodeoxyglucose PET for the exclusion of bvFTD when normal, whereas non-specific regional metabolism abnormalities should not be over-interpreted in the case of a psychiatric differential diagnosis. We highlight the potential role of serum or CSF neurofilament light chain to differentiate bvFTD from primary psychiatric disorders. Finally, based on the increasing literature and clinical experience, the consortium determined that screening for C9orf72 mutation should be performed in all possible/probable bvFTD cases or suspected cases with strong psychiatric features.

1 January 2016 in Annals of Indian Academy of Neurology
Verified
Journal Article
Open access
PDF file
RERatnavalli Ellajosyula
Ratnavalli Ellajosyula
SHSoumya Hegde
Soumya Hegde
Capacity to make one's own decisions is fundamental to the autonomy of the individual. Capacity is a functional assessment made by a clinician to determine if a patient is capable of making a specific decision. Competency is a global assessment and legal determination made by a judge in court. Capacity evaluation for a patient with dementia is used to determine whether the patient is capable of giving informed consent, participate in research, manage their finances, live independently, make a will, and have ability to drive. Patients with dementia cannot be assumed to have impaired capacity. Even a patient with moderate or severe dementia, with obviously impaired capacity may still be able to indicate a choice and show some understanding. Four key components of decision-making in a capacity evaluation include understanding, communicating a choice, appreciation, and reasoning. Assessment of capacity requires a direct interview with the patient using open-ended questions and may include both informal and formal approaches depending on the situation and the context. A baseline cognitive evaluation with a simple test to assess executive function is often useful in capacity evaluation. All capacity evaluations are situation specific, relating to the particular decision under consideration, and are not global in scope. The clinician needs to spend adequate time with the patient and the family allaying their anxieties and also consider the sociocultural context. The area of capacity has considerable overlap with law and the clinician treating patients with dementia should understand the complexities of assessment and the implications of impaired capacity. It is also essential that the clinician be well informed and keep meticulous records. It is crucial to strike a balance between respecting the patient autonomy and acting in his/her best interest.

1 March 2002 in International Journal of Infectious Diseases
Verified
Journal Article
Closed access
SMS.N. Madhusudana
S.N. Madhusudana
DND. Nagaraj
D. Nagaraj
MUM. Uday
M. Uday
ERE. Ratnavalli
E. Ratnavalli
MKM. Verendra Kumar
M. Verendra Kumar

24 August 2007 in Journal of the American Geriatrics Society
Verified
Journal Article
Closed access
PDF file
SZSheryl Zimmerman
Sheryl Zimmerman
PSPhilip D. Sloane
Philip D. Sloane
CWChristianna S. Williams
Christianna S. Williams
DDDebra Dobbs
Debra Dobbs
RERatnavalli Ellajosyula
Ratnavalli Ellajosyula
DKDaniel I. Kaufer
Daniel I. Kaufer

1 April 2018 in Journal of Stroke and Cerebrovascular Diseases
Verified
Journal Article
Closed access
SKSuruliraj Karthikbabu
Suruliraj Karthikbabu
CMChakrapani Mahabala
Chakrapani Mahabala
SGSailakshmi Ganesan
Sailakshmi Ganesan
RERatnavalli Ellajosyula
Ratnavalli Ellajosyula
JSJohn M. Solomon
John M. Solomon